These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15566515)

  • 21. HFE genotyping in patients with elevated serum iron indices and liver diseases.
    Evangelista AS; Nakhle MC; de Araújo TF; Abrantes-Lemos CP; Deguti MM; Carrilho FJ; Cançado EL
    Biomed Res Int; 2015; 2015():164671. PubMed ID: 25654085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
    Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM
    Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
    Zaloumis SG; Allen KJ; Bertalli NA; Turkovic L; Delatycki MB; Nicoll AJ; McLaren CE; English DR; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    J Gastroenterol Hepatol; 2015 Apr; 30(4):719-25. PubMed ID: 25311314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
    Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hfe mutations and iron overload in patients with alcoholic liver disease.
    Costa-Matos L; Batista P; Monteiro N; Henriques P; Girão F; Carvalho A
    Arq Gastroenterol; 2013; 50(1):35-41. PubMed ID: 23657305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
    Shiono Y; Ikeda R; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Imaizumi Y; Yano M; Yoshioka K; Kawanaka M; Yamada G
    Intern Med; 2001 Sep; 40(9):852-6. PubMed ID: 11579943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver pathology in compound heterozygous patients for hemochromatosis mutations.
    Schöniger-Hekele M; Müller C; Polli C; Wrba F; Penner E; Ferenci P
    Liver; 2002 Aug; 22(4):295-301. PubMed ID: 12296962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
    Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
    Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic expression of a novel C282Y/R226G compound heterozygous state in HFE hemochromatosis: molecular dynamics and biochemical studies.
    Cézard C; Rabbind Singh A; Le Gac G; Gourlaouen I; Ferec C; Rochette J
    Blood Cells Mol Dis; 2014 Jan; 52(1):27-34. PubMed ID: 23953397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance-associated hepatic iron overload.
    Mendler MH; Turlin B; Moirand R; Jouanolle AM; Sapey T; Guyader D; Le Gall JY; Brissot P; David V; Deugnier Y
    Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemochromatosis genotypes and risk of iron overload--a meta-analysis.
    Neghina AM; Anghel A
    Ann Epidemiol; 2011 Jan; 21(1):1-14. PubMed ID: 20800508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
    Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
    Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
    Lee D; Jeong SH; Lee M; Cho YA; Kim JW; Park Y; Hwang JH; Kim NY; Lee DH
    Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
    Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
    J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Iron in the era of molecular biology].
    Deugnier Y; Moirand R; Brissot P; David V
    Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.